are glp 1 agonists safe MYTH BUSTER #1 “Weight-loss injections like GLP-1 medicines not safe.” Is this really true? GLP-1 receptor (such as Ozempic®) are among the most discussed anti-obesity medicines today. Unfortunately, misinformation on Pharmacological interventions for obesity in
Description
Incretin mimetics considerably expanded their proven benefits beyond obesity in 2024

2 GLP-1R monotherapy (e.g., semaglutide) is highly effective, but dual GLP-1R/GIPR agonists (e.g.,
David Joffe, BSPharm, CDE Tina Burge, PharmD Candidate Florida A&M University Kiet Ngo, Pharm D Candidate Mercer University Abnormalities in incretin
We further explore the potential actions of multi-agonist drugs as well as the mechanisms through which gut-brain communication can be used to achieve long-term weight loss without negative side effects

Diabetes mellitus is a major risk factor for both cardiovascular and chronic kidney disease (CKD) while CKD is also associated with cardiovascular morbidity

Learn more.
